Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Debt, Earnings Pressures Put Squeeze on Valeant

As Valeant Pharmaceuticals (VRX) prepares to roll out its second-quarter earnings before the opening bell Tuesday, investors should keep a close eye on the "limited breathing room" Valeant has in attempting to avoid breaching covenants on some of its $31 billion in debt, Canaccord analyst Neil Maruoka said in a Monday investment note.

As Real Money reported, if the Canadian drug maker drops its earnings estimates for the year again, this would be the second time so far this year. It stands at particular risk of violating a minimum of interest-coverage ratio on a 1.6 billion tranche of bonds coming due in 2018, on...


More